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Lead exposure raises superoxide and hydrogen peroxide in
human endothelial and vascular smooth muscle cells
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Division of Nephrology and Hypertension, University of California, Irvine, Irvine, California
Lead exposure raises superoxide and hydrogen peroxide in hu-
man endothelial and vascular smooth muscle cells.
Background. Chronic lead exposure causes hypertension and
cardiovascular disease, which are associated with, and, in part,
due to oxidative stress. While occurrence of oxidative stress in
lead-exposed animals and cultured endothelial cells has been
well-established, direct and specific evidence on the type of the
reactive oxygen species (ROS) produced by lead-exposed vas-
cular cells is lacking and was investigated.
Methods. Human coronary endothelial (EC) and vascular
smooth muscle cells (VSMC) were incubated in appropriate
culture media in the presence of either 1 ppm or 10 ppm lead
acetate or sodium acetate (control) for 1 to 30 minutes or
60 hours. Productions of superoxide and hydrogen peroxide in
the cell populations were determined by flow cytometry using
hydroethidine and dihydrorhodamine, respectively. Data from
a minimum of 10,000 cells were collected and analyzed using
Cell Quest software. In addition, Cu Zn superoxide dismutase
(SOD), catalase, glutathione peroxidase (GPX), and NAD(P)H
oxidase (gp91phox) were measured.
Results. Short-term lead exposure resulted in a significant
rise in both superoxide and hydrogen peroxide production by
both EC and VSMC. After long-term exposure, detectable
superoxide levels fell to near normal level, while hydrogen
peroxide production remained high. This was associated with
up-regulations of gp91phox, elevation of superoxide dismutase,
reduction of VSMC catalase, and no change in GPX levels. To-
gether, these events can account for the observed decline in
superoxide and the rise in hydrogen peroxide following long-
term lead exposure.
Conclusion. Lead exposure promotes generation of superox-
ide and hydrogen peroxide in human EC and VSMC. This phe-
nomenon can potentially contribute to the pathogenesis of the
lead-associated hypertension and cardiovascular disease, and
points to the potential benefit of lowering lead burden in the
exposed populations.
Chronic exposure to low levels of lead causes sustained
arterial hypertension (HTN), which persists indefinitely
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after the cessation of lead exposure in humans and ex-
perimental animals [1–9]. In a series of earlier studies
[2–6], we demonstrated that lead-induced HTN is asso-
ciated with oxidative stress and increased production of
reactive oxygen species (ROS). We further showed that
the associated oxidative stress plays a major role in the
pathogenesis of HTN via avid inactivation of nitric oxide
(NO) by ROS [2, 5]. In fact, alleviation of oxidative stress
by a variety of antioxidants resulted in marked amelio-
ration of HTN and enhanced NO availability in rats with
lead-induced HTN [2, 4–6]. Avid inactivation of NO by
ROS was associated with a compensatory up-regulation
of NO synthase (NOS) isoforms that was largely reversed
by antioxidant therapy in lead-treated animals [4–6].
By using a salicylate trapping technique, we recently
found indirect evidence for increased hydroxyl radical
(.OH) generation in the lead-treated rats and cultured
endothelial cells [10, 11]. The role of excess .OH ac-
tivity was further confirmed by the observations that
intravenous administration of the reputed .OH scav-
enger, dimethythiourea (DMTU), ameliorates HTN and
increases urinary excretion of NO metabolites (NOx)
in rats with lead-induced HTN [11]. In contrast, intra-
venous administration of the native superoxide dismu-
tase (SOD) alone or together with catalase had no dis-
cernible effect on either blood pressure or urinary NOx
excretion [12]. However, as a peptide, native SOD is cell
impermeable and, as such, its lack of demonstrable action
does not necessarily preclude increased cellular produc-
tion of superoxide. In an attempt to overcome this obsta-
cle, we recently used the cell-permeable SOD-mimetic
agent, tempol, in a study designed to explore the effect
of lead exposure on superoxide production in cultured
human coronary endothelial cells. The results revealed
reversal of both lipid peroxidation and compensatory up-
regulation of endothelial NO synthase (eNOS) expres-
sion by the SOD-mimetic drug, tempol, in lead-treated
endothelial cells [13]. The latter study provided strong
but indirect evidence for increased superoxide produc-
tion in lead-treated endothelial cells. These in vitro find-
ings were subsequently confirmed by our in vivo studies,
which showed amelioration of HTN and oxidative stress
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together with enhanced NO availability and reversal of
compensatory up-regulation of NOS isoforms by tem-
pol administration in rats with lead-induced HTN [6].
In an attempt to explore the mechanism of oxidative
stress induced by lead exposure, we recently determined
protein abundance of several antioxidant enzymes, in-
cluding SOD isoforms, catalase (CAT), and glutathione
peroxidase (GPX), as well as superoxide-generating en-
zyme, NAD(P)H oxidase, in various tissues of rats with
lead-induced hypertension. The results showed mild up-
regulation of NAD(P)H oxidase and no evidence of
quantitative deficiency of the measured antioxidant en-
zymes [14].
The present study was undertaken to determine di-
rectly the effect of lead exposure on production of
superoxide and hydrogen peroxide in cultured human en-
dothelial cells, as well as human vascular smooth muscle
cells.
METHODS
Cell culture
Human coronary artery endothelial cells and human
vascular smooth muscle cells (Cambrex Bio Science,
Walkersville, Inc., Walkersville, MD, USA) were cultured
in a manner that was described in our earlier studies [13].
Cells obtained on passages 3 and 4 were used. Once a
70% confluence was reached, the cells were incubated in
a medium containing either 1 ppm or 10 ppm lead acetate
for 5, 10, 30 minutes (short-term study), or for 60 hours
(long-term study). Cells treated with the identical con-
centrations of sodium acetate were used as controls. The
given time course was selected in order to dissect the
rapid actions of lead on the vascular cells from the su-
perimposed compensatory and genomic alterations that
might occur with long-term exposure. The lead concen-
tration range employed here is consistent with those used
in previous in vitro studies [10]. Although plasma lead
levels observed with chronic lead exposure in humans
are usually below those used in the in vitro studies, tissue
concentrations (kidney, bone, brain) are frequently very
high. This supposition is based on animal studies that have
revealed 10- to 140-fold higher lead concentrations in the
kidney than in the blood following long-term lead expo-
sure [15, 16]. In this context, the lead concentration range
employed in the present tissue culture study is at or below
those found in the kidneys of rats exposed to low levels of
lead for extended periods. Thus, the lead concentration
range employed in the tissue culture experiments here
are biologically relevant.
Flow cytometry
At the conclusion of each incubation period, the cells
were loaded with either 5 lmol/L hydroethidine (HE)
or 2.5 lmol/L dihydrorhodamine 123 (DHR) (Molecular
Probe, Inc., Eugene, OR, USA) for 3 hours for measure-
ments of superoxide and hydrogen peroxide, respectively.
Cells were then washed with phosphate-buffered saline
(PBS) buffer, trypsinized, and maintained in PBS at 4◦C
before being analyzed by flow cytometry (FACSort, Bec-
ton Dickinson, San Jose, CA, USA). This instrument was
equipped with an Argon laser for excitation at 488 nm.
The emission for DHR was collected at FL1 detector
(530/30 nm) and that of HE at FL2 detector (585/42 nm).
Generally, data from 10,000 cells were collected and an-
alyzed using Cell Quest software (Becton Dickinson).
Measurements of SOD, catalase, glutathione peroxidase,
and NAD(P)H oxidase
Protein abundance of the above molecules in the cell
preparations was determined by Western blot analysis us-
ing antibodies against CuZn SOD, catalase, glutathione
peroxidase (Calbiochem, Inc., San Diego, CA, USA),
and gp91phox subunit of NAD(P)H oxidase (Transduction
Laboratories, Lexington, KY, USA) as described previ-
ously [17, 18].
CuZn SOD enzymatic activity was determined using
the Bioxytech SOD-525TM Kit purchased from OXIS In-
ternational (Portland, OR, USA).
Statistical analysis
Flow cytometry data were acquired and analyzed by
Cell Quest Software (Becton Dickinson). Analysis of
variance (ANOVA) and Student t test were used in the
statistical evaluation of the data using Sigma Stat Soft-
ware (Microsoft Group, Chicago, IL, USA). Data are
presented as mean ± SEM. P values less than 0.05 were
considered significant.
RESULTS
Short-term studies
Smooth muscle cells. Data are illustrated in Figure 1.
Significant elevation of superoxide and hydrogen perox-
ide was observed in vascular smooth muscle cells treated
with 1 ppm lead acetate for 5 to 10 minutes. Likewise,
a significant increase in both superoxide and hydrogen
peroxide was observed at 5, 10, and 30 minutes in cells
incubated in the medium containing 10 ppm lead acetate.
Endothelial cells. Data are summarized in Figure 2.
Exposure to 1 ppm lead acetate resulted in a signifi-
cant rise in superoxide production at 5 to 10 minutes.
Increased superoxide production was evident at 5, 10,
and 30 minutes in endothelial cells exposed to 10 ppm
lead acetate. Hydrogen peroxide production was signifi-
cantly increased in the endothelial cells exposed to either
1 or 10 ppm lead throughout the 30-minute observation
period.
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Fig. 1. Representative overlayed histograms
and group data depicting superoxide and
H2O2 production by human coronary artery
smooth muscle cells incubated in lead acetate
(at 1 ppm or 10 ppm), or equivalent concentra-
tions of Na acetate (CTL) for 5 to 30 minutes.
The increase in fluorescence intensity in the
lead-treated cells is shown as a rightward shift
on the x-axis. ∗P < 0.05; ∗∗P < 0.01, N = 9.
Long-term studies
Smooth muscle cells. Data are shown in Figure 3. The
production of hydrogen peroxide was significantly in-
creased in the cells incubated for 60 hours with either
1 ppm or 10 ppm lead acetate as compared with that found
in the control cells. However, the generation of superox-
ide in the two lead-treated groups did not significantly
differ from that found in the control groups.
Endothelial cells. Data are depicted in Figure 4.
As with the vascular smooth muscle cells, a signifi-
cant elevation of hydrogen peroxide production was
observed in human coronary artery endothelial cells
treated with either 1 ppm or 10 ppm lead acetate for 60
hours. No significant difference was found in superox-
ide production between the lead-treated and the control
cells.
SOD data. Data are shown in Figure 5. Immunode-
tectable Cu Zn SOD abundance rose significantly both in
endothelial and vascular smooth muscle cells incubated
with either 1 ppm or 10 ppm lead acetate for 60 hours. This
was accompanied by a significant but less pronounced
rise in CuZn SOD activity in the vascular smooth muscle
cells and an insignificant rise in the corresponding values
in endothelial cells exposed to 10 ppm lead acetate for
60 hours.
Catalase data. Data are shown in Figure 6. Long-
term exposure to lead acetate resulted in a significant
concentration-dependent decline in immunodetectable
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Fig. 2. Representative overlayed histograms
and group data demonstrating superoxide and
H2O2 production by human coronary artery
endothelial cells incubated in lead acetate (at
1 ppm or 10 ppm), or equivalent concentra-
tions of Na acetate (CTL) for 5 to 30 minutes.
The increase in fluorescence intensity in the
lead-treated cells is shown as a rightward shift
on the x-axis. ∗P < 0.05; ∗∗P < 0.01, N = 9.
catalase in cultured vascular smooth muscle cells. How-
ever, long-term exposure to lead at the given concentra-
tions did not significantly affect catalase abundance in
cultured endothelial cells.
Glutathione peroxidase data. Data are given in
Figure 6. Despite increased hydrogen peroxide produc-
tion, GPX abundance remained virtually unchanged in
both cultured endothelial and vascular smooth muscle
cells exposed to lead for 60 hours.
gp91phox data. Data are illustrated in Figure 7. Expo-
sure of endothelial cells to lead resulted in a significant
up-regulation of gp91phox subunit of NAD(P)H oxidase,
a well-known source of superoxide. Unlike endothelial
cells, vascular smooth muscle cells do not express gp91phox
and tested negative for this protein.
DISCUSSION
The present study revealed that exposure to lead re-
sults in a rise in superoxide and hydrogen peroxide pro-
duction directly measured by flow cytometry in human
coronary endothelial cells. These observations are con-
sistent with the indirect evidence found in our earlier
studies in cultured endothelial cells [10, 13] and rats with
lead-induced HTN [6, 12, 11]. In addition, lead exposure
caused an increase in superoxide and hydrogen peroxide
generation in human vascular smooth muscles. Accord-
ingly, the study demonstrated the contribution of both en-
dothelial and vascular smooth muscle cells to the patho-
genesis of lead-induced oxidative stress in the vascular
tissues. In addition to causing HTN, chronic exposure
to lead results in a marked increase in the development of
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Fig. 3. Representative overlayed histograms and group data depicting
superoxide and H2O2 production by human coronary artery smooth
muscle cells incubated in lead acetate (at 1 ppm or 10 ppm), or equiv-
alent concentrations of Na acetate (CTL) for 60 hours. The increase in
fluorescence intensity in the lead-treated cells is shown as a rightward
shift on the x-axis. ∗P < 0.05, N = 9.
arteriosclerotic cardiovascular disease [1, 19]. Oxidative
stress plays a central role in the pathogenesis of athero-
and arteriosclerosis. As described in several recent
reviews [20, 21], oxidative stress can lead to endothe-
lial dysfunction, HTN, and altered vascular function and
structure by several mechanisms. For instance, inactiva-
tion of nitric oxide by ROS can result in vasoconstriction,
increased platelet/leukocyte adhesion, vascular smooth
muscle cell migration/proliferation, and matrix accumu-
lation leading to vascular remodeling. In addition, via
activation of the redox-sensitive nuclear factor, NFjB,
and consequent generation of proinflammatory and profi-
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Fig. 4. Representative overlayed histograms and group data depicting
superoxide and H2O2 production by human coronary artery endothe-
lial cells incubated in lead acetate (at 1 ppm or 10 ppm), or equivalent
concentrations of Na acetate (CTL) for 60 hours. The increase in fluo-
rescence intensity in the lead-treated cells is shown as a rightward shift
on the x-axis. ∗P < 0.05; ∗∗P < 0.01, N = 9.
brotic cytokines, oxidative stress can promote inflamma-
tion, which is an important component of atherogenesis.
Moreover, ROS-mediated endothelial injury and gen-
eration of atherogenic oxidized lipids/lipoproteins can
contribute to cardiovascular consequences of oxidative
stress. Thus, increased ROS generation by the vascular
cells may be an important link in development of ischemic
cardiovascular disease in the lead-exposed populations.
Cells employed here were the product of primary cul-
ture of human coronary artery endothelial and vascu-
lar smooth muscle cells studied after only 3 to 4 passes
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Fig. 5. Representative Western blot and
group data depicting Cu-Zn SOD protein
abundance and enzymatic activity in hu-
man coronary artery endothelial and vascu-
lar smooth muscle cells incubated in lead ac-
etate (at 1 ppm or 10 ppm), or equivalent con-
centrations of Na acetate (CTL) for 60 hours.
∗P < 0.05 vs CTL; ∗∗P < 0.01 vs. 1 ppm and
CTL, N = 9.
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Fig. 6. Representative Western blots and
group data depicting catalase and glutathione
peroxidase (GPX) in human coronary artery
endothelial and vascular smooth muscle cells
incubated in lead acetate (at 1 ppm or 10
ppm), or equivalent concentrations of Na ac-
etate (CTL) for 60 hours. ∗P < 0.05 vs. CTL;
∗∗P < 0.01 vs. 1 ppm and CTL, N = 9.
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Fig. 7. Representative Western blot and group data depicting gp91phox
abundance in human coronary endothelial cells incubated in media con-
taining lead acetate (1 or 10 ppm), or equivalent concentration of Na
acetate (CTL) for 60 hours. ∗P < 0.05.
to avoid transformation. For these reasons, the data ob-
tained can have clinical relevance.
It is of note that short-term exposure to lead re-
sulted in significant elevations of both superoxide and
H2O2, whereas chronic lead exposure resulted in eleva-
tion of H2O2, but not superoxide, in both endothelial and
vascular smooth muscle cells. This phenomenon can be
explained by the compensatory up-regulation of super-
oxide dismutase (SOD), which catalyzes dismutation of
superoxide to H2O2, and hence, reduction of superox-
ide and elevation of H2O2 in the chronic phase. In ad-
dition, concurrent rise in NO production, occasioned by
up-regulation of endothelial NO synthase, shown in our
earlier studies [13], may contribute to the decline in de-
tectable superoxide. This is based on the great affinity of
superoxide for reaction with NO. Since SOD expression
is regulated by its substrate, superoxide, stimulation of
superoxide production by lead can account for the com-
pensatory up-regulation of SOD in cells exposed to lead
for extended periods. Hydrogen peroxide is converted
to water by catalase (2 H2O2 Catalase−−−→ 2H2O + O2) and
GPX, which utilizes glutathione (GSH) as electron donor
(H2O2 + 2GSH GPX−→ 2H2O + GS-SG). In contrast to
the CuZn SOD, CAT abundance declined significantly in
chronically lead-exposed vascular smooth muscle cells,
and insignificantly in the endothelial cells, while GPX re-
mained unchanged. Given the critical role of catalase and
GPX in detoxification of hydrogen peroxide and lipoper-
oxides, the observed reduction or lack of a compensatory
up-regulation of these enzymes undoubtedly contributes
to oxidative stress and H2O2 accumulation in the lead-
exposed endothelial and vascular smooth muscle cells.
NAD(P)H oxidase isoforms have emerged as a major
source of ROS in the vascular tissue [22]. We therefore
sought to assess the effect of long-term lead exposure
on immunodetectable NAD(P)H oxidase in the human
endothelial and vascular smooth muscle cells. The study
showed a significant up-regulation of gp91phox subunit of
this enzyme in the lead exposed endothelial cells. This ob-
servation points to up-regulation of NAD(P)H oxidase
as a potential source of ROS in lead-exposed endothelial
cells. It is of note that gp91phox is not expressed in the vas-
cular smooth muscle cells and, as such, was not detected
here.
Unlike the in vivo condition, wherein vascular cells are
influenced by a myriad of hemodynamic forces, neuronal
stimuli, humoral factors, and interaction with other cell
types, such as leukocytes and platelets, these confound-
ing factors are absent in vitro. Thus, increased ROS gen-
eration in lead-exposed endothelial and vascular smooth
muscle cells in vitro points to the direct effect of lead in
promoting oxidative stress in the vascular tissue. These
observations support the potential benefit of the reduc-
tion in lead burden by preventing further exposure and
promoting lead excretion in the affected persons.
CONCLUSION
Lead exposure promotes generation of superoxide and
hydrogen peroxide in the cellular components of the vas-
cular wall. This phenomenon can contribute to the patho-
genesis of the associated hypertension and cardiovascu-
lar disease and points to the potential benefit of lowering
lead burden in the exposed populations.
LIST OF ABBREVIATIONS
18-OH-THA 18-OH-tetrahydro-11-dehydrocorticosterone
5a-THB 5a-tetrahydro-corticosterone
5a-THF 5a-tetrahydro-cortisol
BMI Body mass index
CMO Corticosterone methyl oxidase
CMO-II Corticosterone methyl oxidase type II
CYP11B1 11b-hydroxylase
CYP11B2 Aldosterone synthase
DOC 11-deoxycorticosterone
GC-MS Gas chromatography-mass spectrometry
MO Methyl oxidase
Substance B Corticosterone
Substance S 11-deoxy-17-hydroxycorticosterone
THA Tetrahydro-11-dehydrocorticosterone
THAldo Tetrahydro-aldosterone
THB Tetrahydro-corticosterone
THDOC Tetrahydro-11-deoxycorticosterone
THE Tetrahydro-cortisone
THF Tetrahydro-cortisol
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